InNexus Biotechnology Inc., of Vancouver, British Columbia, appointed J. Donald Capra chairman of its newly formed scientific advisory board.

Jefferies & Co. Inc., of New York, hired Peter Bye as a managing director and senior equity research analyst covering medical devices and diagnostics companies.

Metabolic Research Inc., of Montgomery, Texas, added S.N. Chen to its scientific advisory board.

MonoGen Inc., of Montreal, promoted Ted Geiselman to president and CEO. His predecessor, Norman Pressman, was appointed executive chairman, while retaining his position as the chief scientific officer.

Nektar Therapeutics Inc., of San Carlos, Calif., promoted Nevan Elam to senior vice president, head of the pulmonary business unit. It also named Tim Warner senior vice president, investor relations and corporate affairs; Stephan Herrera senior director, investor relations and corporate affairs; and Gil Labrucherie general counsel and secretary.

Neuralstem Inc., of Rockville, Md., appointed John Conron chief financial officer.

Oramed Pharmaceuticals Inc., of Jerusalem, added Harold Jacob to its advisory board.

Phase Bioscience Inc., of Durham, N.C., appointed M. Nixon "Nick" Ellis president, CEO and director.